In summary, our study elucidates the clinical significance of MB21D2 expression in ESCC and demonstrates MB21D2 modulates the biological functions of ESCC by influencing the Wnt/β-catenin signaling pathway at the cellular level. The gene discussed is MB21D2; the disease is esophageal squamous cell carcinoma.